What the trials actually show
Short answer: on bloating, the evidence for multi-herb blends is real but thinner than the packaging suggests, and the best available trial testing a blend head-to-head against a simpler version found no advantage for the longer ingredient list. That is the honest state of it.
The most direct bloating evidence comes from the IBO-2 study, published in Neurogastroenterology & Motility in 2025. Thirty-two patients with functional dyspepsia were given a six-herb preparation or placebo for two weeks, then had gas infused into the stomach under laboratory conditions.
Gas evacuation was faster on the herbal blend, 319 mL versus 80 mL at twenty minutes, p equals 0.015. Perceived bloating rose less, 0.8 versus 2.1, p equals 0.036. Measured abdominal girth, though, showed no significant difference at all.
Does more herbs mean more relief?
This is where the tidy story breaks. If combining herbs worked by simple addition, a longer list would beat a shorter one. Researchers tested roughly that question, and the result is the most inconvenient fact in this whole field.
A three-arm trial in dysmotility-type functional dyspepsia compared the original nine-herb preparation, a reduced six-herb version of the same product, and the prokinetic drug cisapride across 183 patients over four weeks. The full formula and the trimmed formula performed equivalently.
Three of the nine herbs came out, and nothing measurable was lost. That does not mean blends fail. It means the count of ingredients on a label is not the variable doing the work, and no trial has yet shown that adding a tenth or eighteenth herb adds anything at all.
“Three of the nine herbs came out, and nothing measurable was lost. The count of ingredients on a label is not the variable doing the work.”
The case researchers make for blends
The scientists who favour combinations are not making it up, and their argument deserves to be stated properly. A 2017 review in Wiener Medizinische Wochenschrift argues that the blend works through a multitarget effect, hitting several causes of the same symptom at once.
Bloating is not one malfunction. It involves how fast the stomach empties, how the gut wall handles pressure, whether there is spasm, and how sensitive the nerves are. A single herb tends to act on one of those. That review states the components of the combination act synergistically.
Synergy is a strong word, and it is the crux of the disagreement. If it holds, a blend does something the parts cannot. If it does not, a blend is simply several herbs sharing a cup.
NWhat the research says
"Perception of abdominal symptoms, mainly bloating, was significantly lower in patients treated with the herbal preparation, a mean score increment of 0.8 versus 2.1 on placebo, though abdominal girth did not differ."
— The IBO-2 Study, Neurogastroenterology & Motility
Is one herb ever enough?
Here is what the pro-blend literature tends to leave out. That same 2017 review does not discuss methodological limits, heterogeneity, or evidence gaps anywhere in its text, and several of its authors are affiliated with the manufacturer of the preparation it praises.
The IBO-2 bloating study was funded by Steigerwald Arzneimittelwerk, the maker. Its authors list the small sample and an overrepresentation of women among its limitations, and note the gas volumes used sat at the upper limit of a normal meal. Laboratory conditions, not a Tuesday evening.
And in 2020 a Cochrane team registered a protocol to review this exact preparation under strict methodology. That protocol was retracted in June 2021. The independent review was never completed.
Two herbs have been tested together often enough to say something concrete, and the result is instructive precisely because it is modest rather than dramatic.
Reading a tea label honestly
A 2019 randomised controlled trial in Clinical and Translational Gastroenterology tested caraway oil with L-menthol in 95 patients meeting Rome III criteria for functional dyspepsia. At twenty-four hours, postprandial distress symptoms fell significantly, p equals 0.039. Across the full population at two to four weeks, there was no statistically significant difference.
Two herbs, one clear early signal, then the effect thinned out. The authors flagged concomitant medication as a source of treatment heterogeneity. That is roughly the shape of this evidence base: real short-term signals, honest uncertainty about anything longer.
This is the part worth carrying into a shop. All Day Slimming Tea lists eleven ingredients in its morning blend and twelve in its evening one, including senna leaves, licorice root, peppermint, fennel fruit, lemongrass and ginger.
Why did the old tricks stop working?
On the evidence above, that list length is not itself a reason to expect more. Senna is the one to read carefully: it is a stimulant laxative, and the effect people notice first is bowel movement, not fat loss. The maker suggests three servings daily and offers a sixty-day money-back window.
If a blend helps, the honest expectation is digestive comfort and less distension, on the same modest scale the trials measured. Nothing in this literature supports treating a tea as weight-loss treatment.
Many women arrive at this question after years of things quietly failing, and that history deserves naming before any herb does. A decade of attempts that stopped working was not a character flaw. The underlying conditions changed, and nobody explained the change.
That matters here because it shapes what a tea can honestly be. A hormonal transition is not something a blend corrects, and no trial above tested hormones. What the trials tested was digestive comfort under pressure, over weeks, in small groups.
What would settle the argument
So the fair framing is narrow. A herbal blend sits alongside what is within daily reach, evening routine and digestion, and not in place of medical care. A blend with an honest scope is worth more than a promise with none.
The study nobody has run yet is the simple one: a blend against one of its own herbs, alone, in people whose main complaint is bloating, measured over months rather than a laboratory afternoon.
Until that exists, both positions stay defensible. The multitarget argument is mechanistically plausible and has one funded bloating trial behind it. The sceptical reading, that an eighteen-item label is marketing rather than pharmacology, has the equivalence finding and the retracted Cochrane protocol behind it.
Bloating that never eases overnight, or arrives with pain, bowel changes or unexplained weight loss, is a reason to see a doctor promptly rather than to try another cup. That part is not contested by anyone.